Bioorthogonal Chemistry: Enzyme Immune and Protein Capture for Enhanced LC-MS Bioanalysis

• Published in: Bioconjugate chemistry 2024-11, Vol.35 (11), p.1699-1710
• Main Authors: Wang, Xiaotong, Hu, Duanmin, Wang, Perry G., Yang, Shuang
• Format: Article
• Language: English
• Subjects: Animals; Biomolecules; Chemical synthesis; Chemistry; Chromatography, Liquid - methods; Click Chemistry; Drug development; Drug discovery; Drug Discovery - methods; Enzymes - chemistry; Enzymes - metabolism; Humans; Liquid chromatography; Liquid Chromatography-Mass Spectrometry; Marking and tracking techniques; Mass spectrometry; Mass Spectrometry - methods; Mass spectroscopy; Peptides; Proteins; Proteins - analysis; Proteins - chemistry; Sensitivity analysis; Solid phases
• ISSN: 1043-1802; 1520-4812; 1520-4812
• DOI: 10.1021/acs.bioconjchem.4c00423

Immunocapture liquid chromatography–mass spectrometry (IC-LC-MS) bioanalysis has become an indispensable technique across various scientific disciplines, ranging from drug discovery to clinical diagnostics. While traditional immunocapture techniques have proven to be effective, they often encounter limitations in sensitivity, specificity, and compatibility with MS analysis. Chemoenzymatic immunocapture and protein capture (IPC) offers a promising solution, combining the high specificity of antibodies or proteins with the versatility of enzymatic and chemical modifications. This Review explores the foundational principles of chemoenzymatic IPC and examines various modification strategies including bioorthogonal click-chemistry, enzymatic-tagging, and HaloTag/CLIP-tag. Recent advancements in chemoenzymatic IPC techniques have significantly expanded their applicability to a diverse range of biomolecules including small molecules, peptides, RNAs, and proteins. This Review focuses on improvements in analytical performance achieved through these innovative approaches. Moreover, we discuss the broad applications of chemoenzymatic immunocapture in drug discovery, clinical diagnostics, and environmental analysis and explore its potential for future advancements in bioanalysis. We propose a novel solid-phase chemoenzymatic IPC assay (SCEIA) that effectively utilizes bioorthogonal click chemistry and chemoenzymatic approaches for efficient IPC and target analyte release. In summary, chemoenzymatic IPC represents a transformative paradigm shift in IC-LC-MS bioanalysis. By overcoming the limitations of traditional IPC techniques, this approach paves the way for more robust, sensitive, and versatile analytical workflows.